Tactile Systems TechnologyTCMD
About: Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Employees: 992
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
276% more call options, than puts
Call options by funds: $158K | Put options by funds: $42K
46% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 37
1.83% more ownership
Funds ownership: 92.63% [Q1] → 94.46% (+1.83%) [Q2]
3% less funds holding
Funds holding: 135 [Q1] → 131 (-4) [Q2]
15% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 27
25% less capital invested
Capital invested by funds: $355M [Q1] → $268M (-$87.5M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
B. Riley Securities | 60%upside $23 | Buy Initiated | 26 Sept 2024 |
Financial journalist opinion
Based on 6 articles about TCMD published over the past 30 days
